Patents by Inventor David Jarrossay

David Jarrossay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240133306
    Abstract: A turbine engine nozzle extending about an axis and including a vane assembly mounted between an outer shroud and an inner shroud; and a position retaining device configured to be placed in an elastically prestressed state between the inner shroud and an inner platform of the vane assembly to apply a stress on the vane assembly towards the outer shroud. The contact between the inner shroud and the inner platform is obtained by one same surface of the position retaining device.
    Type: Application
    Filed: February 8, 2022
    Publication date: April 25, 2024
    Applicants: SAFRAN AIRCRAFT ENGINES, SAFRAN CERAMICS
    Inventors: Sébastien Serge Francis CONGRATEL, Aurélien GAILLARD, Matthieu Arnaud GIMAT, Clément JARROSSAY, David René Pierre LE CAIR
  • Patent number: 9347043
    Abstract: The invention relates to methods of producing antibodies, including monoclonal antibodies, comprising culturing a limited number of plasma cells. It also relates to methods of identifying antibodies by performing assays on the antibodies produced by the cultured plasma cells to determine their function, binding specificity, epitope specificity, and/or their ability to neutralize a toxin or a pathogen. The invention also relates to antibodies and antibody fragments produced by the methods of the invention as well as methods of using the antibodies and antibody fragments.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: May 24, 2016
    Assignee: Institute for Research in Biomedicine
    Inventors: Antonio Lanzavecchia, David Jarrossay
  • Publication number: 20100145031
    Abstract: The invention relates to methods of producing antibodies, including monoclonal antibodies, comprising culturing a limited number of plasma cells. It also relates to methods of identifying antibodies by performing assays on the antibodies produced by the cultured plasma cells to determine their function, binding specificity, epitope specificity, and/or their ability to neutralize a toxin or a pathogen. The invention also relates to antibodies and antibody fragments produced by the methods of the invention as well as methods of using the antibodies and antibody fragments.
    Type: Application
    Filed: October 22, 2009
    Publication date: June 10, 2010
    Applicant: INSTITUTE FOR RESEARCH IN BIOMEDICINE
    Inventors: Antonio Lanzavecchia, David Jarrossay
  • Patent number: 6143567
    Abstract: The lysis of erythrocytes is accomplished by subjecting whole blood treated with an anticoagulant at a pH between 4 and 9 with a nitrogenous heterocyclic compound, most preferably pyrrolidine chloride.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: November 7, 2000
    Assignee: Immunotech
    Inventors: Andre Van Agthoven, David Jarrossay